Eli Lilly halted two late-stage clinical trials of an experimental Alzheimer's treatment on Tuesday, representing a setback to one leading theory on treating the degenerative disease and a new blow to Lilly's business prospects.
44251
Eli Lilly halts two clinical trials of an experimental Alzheimer's treatment
2155
Drug stocks slip;
101889
Alzheimer's may cause global cash crunch: experts
105490
Lind may be headed to disabled list
105609
Germany's Merck KGaA drops ms drug
10934
FDA lifts partial hold on Icagen drug;
9570
Ramsay Health Care calls trading halt
45526
Eli Lilly cuts 5500 jobs
107867
Rheumatism often treated too late
93581
Psychoanalysis scrapped from health insurance
147261
Lilly to open diabetes research center in China
53230
Pfizer ends trial of experimental cancer drug
126045
Apple loses another patent
168887
Merck to stop testing Isentress after initial trial results
85156
Drug stocks follow market lower;
19593
Drug plans not sustainable
61304
Health officials shoot down approval for weight loss drug